Q32 Bio (QTTB) Non-cash Items (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Non-cash Items of $8.4 million in Q1 2026, up 433.82% quarter-over-quarter from $1.6 million in Q4 2025, and up 787.14% on a YoY basis from $942917.0 in Q1 2025.
Q32 Bio (QTTB) Non-cash Items (2017 - 2026) Analysis & Trends
Q32 Bio's Non-cash Items history runs 10 years deep, the most recent figure standing at $8.4 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 787.14% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $8.4 million (up 787.14% YoY), while the FY2025 annual figure was $1.1 million, up 9435091.67% from the prior year.
- Non-cash Items was $8.4 million for Q1 2026 at Q32 Bio, up from $1.6 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $62.8 million in Q3 2024 to a low of $12.0 in Q4 2024.
- Historically, Non-cash Items has averaged $6.3 million across 5 years, with a median of $962458.5 in 2022.
- The sharpest annual moves came in 2024 and 2025: Non-cash Items plunged 99.89% in 2024, then surged 13058233.33% in 2025.
- A 5-year view of Non-cash Items shows it stood at $493000.0 in 2022, then tumbled by 97.83% to $10712.0 in 2023, then slumped by 99.89% to $12.0 in 2024, then soared by 13058233.33% to $1.6 million in 2025, then soared by 433.82% to $8.4 million in 2026.
- The last three Non-cash Items figures came in at $8.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 942,917.00 |
| Mar 31, 2025 | 942,917.00 |
| Dec 31, 2024 | 12.00 |
| Dec 31, 2024 | 12.00 |
| Sep 30, 2024 | 62.83 Mn |
| Sep 30, 2024 | 62.83 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 670,992.00 |
| Mar 31, 2024 | 670,992.00 |
| Dec 31, 2023 | 10,712.00 |
| Dec 31, 2023 | 10,712.00 |
| Sep 30, 2023 | 7.57 Mn |
| Sep 30, 2023 | 7.57 Mn |